Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa
Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. · 2010
Read Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa by Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012873.txt.
Description
Jaoko, Karita, Kayitenkore and co-authors ran an early safety trial in Africa of a two-step HIV vaccine plan. Their 2010 study was a double-blind trial with placebo control, the strictest kind of early test. Volunteers received a recombinant adenovirus vaccine carrying HIV Gag and Pol genes, alone or after a DNA vaccine prime.
The team measured safety and how strongly immune systems answered. Early trials like this one decide whether a vaccine idea earns larger tests. Running them in Africa also ensures the data fit the populations most affected by HIV.
Catalog record
| CREATOR | Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012873